SELUTION4BTK Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 376 participants.

Also called NCT05055297

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 376 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05055297
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Austria, France, Germany, Hong Kong SAR China, Italy, Netherlands, New Zealand, Singapore, Switzerland (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05055297. Randomized; single masking; primary purpose treatment. Start 2022-05-19 (actual); primary completion 2027-06-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
SELUTION4BTK Trial
Condition
Peripheral Arterial Disease
Condition
Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities
Intervention (Device)
SELUTION SLR™ DEB 014
Intervention (Device)
Plain (Uncoated) Balloon Angioplasty (PTA)
Lead sponsor
M.A. Med Alliance S.A. (class: industry)
Collaborator
NAMSA (class: other)
Collaborator
Cordis US Corp. (class: industry)

Record details

Record id
cardio:ct-nct05055297
Content hash
7635adf70472934fabf8c7f50ee5ce90cc63fd740cee979ef733e41a7a58316d